Wi-LAN Inc. (T.WIN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Wi-LAN Inc. (T.WIN)

WILN 1.390

0.0%

Sep 18 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: xanada	6/10/2014 9:53:44 AM
	of 16863

WiLAN Subsidiary Acquires Medical Patent Portfolio OTTAWA, Canada – June 10, 2014 – Wi-LAN Inc. (“WiLAN” or the “Company”) (TSX:WIN) (NASD:WILN) today announced that a subsidiary has acquired a portfolio of medical patents that relate to Stent technology. "With the acquisition of this medical technology, and a strong opportunity pipeline, WiLAN is seeing significant demand from inventors and small companies, in diverse markets, looking to monetize their valuable inventions,” said Jim Skippen, President & CEO. “The acquired technology helps address vascular blood flow complications.” The acquisition of this portfolio will be funded through an upfront payment and the sharing of net revenues generated by licensing the patents. WiLAN can confirm that it does not consider the upfront payment amount to be material relative to its current cash position. All other terms of the agreement are confidential.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next